ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2024

Zinzino group revenue increased with a total of 25 %, compared with the previous year.

GOTHENBURG, Sweden, March 5, 2024 /PRNewswire/ — The revenue in February for Zinzino’s sales markets increased by 27 % and amounted to SEK 138.7 (109.6) million. Faun Pharma’s external sales increased by 11 % and amounted to SEK 9.7 (8.7) million. Overall, the Group increased revenues by 25 % to SEK 148.4 (118.3) million compared with the previous year.

Accumulated revenue for January – February 2024 increased by 20 % to SEK 297.4 (247.8) million.

Revenues were distributed as follows:

Regions,MSEK	24-Feb	23-Feb	Change	YTD 2024	YTD 2023	Change
The Nordics	22.2	23.2	-4 %	45.1	46.8	-4 %
Central Europe	36.7	26.9	36 %	77.6	55.4	40 %
East Europe	29.9	25.2	19 %	61.7	58,0	6 %
South & West Europe	24.6	14.4	71 %	46.6	30.3	54 %
The Baltics	8.3	6.1	36 %	16.3	13.4	22 %
North America	12.2	6.3	94 %	22.5	12.6	79 %
Asia-Pacific	3.6	6.5	-45 %	7.6	11.1	-32 %
Africa	1.2	1,0	20 %	2.2	2.4	-8 %
Zinzino	138.7	109.6	27 %	279.6	230.0	22 %
Faun Pharma	9.7	8.7	11 %	17.8	17.8	0 %
Zinzino Group	148.4	118.3	25 %	297.4	247.8	20 %

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

–Central Europe: Austria, Germany, Switzerland

–East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey

-The Baltics: Estonia, Latvia, Lithuania

–North America: Canada, USA, Mexico

–Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

–Africa: South Africa